Facial Dysmorphisms, Macrodontia, Focal Epilepsy, and Thinning of the Corpus Callosum: A Rare Mild Form of Kabuki Syndrome

Abstract

Kabuki syndrome (KS) is a rare genetic condition with multiple congenital abnormalities and developmental delay. The cardinal manifestations of KS include characteristic facial features, intellectual disability, skeletal defects, dermatoglyphic abnormalities, and postnatal growth deficiencies. Cardiac and urological malformations are commonly present in patient with KS, as well as language deficits and immunological abnormalities. Here, we reported a case of a child with an atypical form of KS, associated with macrodontia, corpus callosum dysmorphism, focal epilepsy responsive to antiepileptic treatment, and a novel KMT2D gene missense variant, c.2413C > T, never reported to date.

Keywords

Kabuki syndrome - KMT2D gene - focal epilepsy

• References

• 1 Matsumoto N, Niikawa N. Kabuki make-up syndrome: a review. Am J Med Genet C Semin Med Genet 2003; 117C (01) 57-65
• 2 Adam MP, Hudgins L. Kabuki syndrome: a review. Clin Genet 2005; 67 (03) 209-219
• 3 Kuroki Y, Suzuki Y, Chyo H, Hata A, Matsui I. A new malformation syndrome of long palpebral fissures, large ears, depressed nasal tip, and skeletal anomalies associated with postnatal dwarfism and mental retardation. J Pediatr 1981; 99 (04) 570-573
• 4 Cantoni S, Fattizzo B. Clinical course and management of adult-onset immune-mediated cytopenia associated with Kabuki syndrome. Eur J Intern Med 2019; 69: e3-e5
• 5 Hoffman JD, Ciprero KL, Sullivan KE. et al. Immune abnormalities are a frequent manifestation of Kabuki syndrome. Am J Med Genet A 2005; 135 (03) 278-281
• 6 Niikawa N, Matsuura N, Fukushima Y, Ohsawa T, Kajii T. Kabuki make-up syndrome: a syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency. J Pediatr 1981; 99 (04) 565-569
• 7 Niikawa N, Kuroki Y, Kajii T. et al. Kabuki make-up (Niikawa-Kuroki) syndrome: a study of 62 patients. Am J Med Genet 1988; 31 (03) 565-589
• 8 Froimchuk E, Jang Y, Ge K. Histone H3 lysine 4 methyltransferase KMT2D. Gene 2017; 627: 337-342
• 9 Shilatifard A. Molecular implementation and physiological roles for histone H3 lysine 4 (H3K4) methylation. Curr Opin Cell Biol 2008; 20 (03) 341-348
• 10 Zhang J, Dominguez-Sola D, Hussein S. et al. Disruption of KMT2D perturbs germinal center B cell development and promotes lymphomagenesis. Nat Med 2015; 21 (10) 1190-1198
• 11 Ortega-Molina A, Boss IW, Canela A. et al. The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development. Nat Med 2015; 21 (10) 1199-1208
• 12 Toska E, Osmanbeyoglu HU, Castel P. et al. PI3K pathway regulates ER-dependent transcription in breast cancer through the epigenetic regulator KMT2D. Science 2017; 355 (6331): 1324-1330
• 13 Bjornsson HT, Benjamin JS, Zhang L. et al. Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome. Sci Transl Med 2014; 6 (256) 256ra135
• 14 Micale L, Augello B, Maffeo C. et al. Molecular analysis, pathogenic mechanisms, and readthrough therapy on a large cohort of Kabuki syndrome patients. Hum Mutat 2014; 35 (07) 841-850
• 15 Ng SB, Bigham AW, Buckingham KJ. et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 2010; 42 (09) 790-793
• 16 Kim SJ, Cho SY, Maeng SH. et al. A novel MLL2 gene mutation in a Korean patient with Kabuki syndrome. Korean J Pediatr 2013; 56 (08) 355-358
• 17 Cocciadiferro D, Augello B, De Nittis P. et al. Dissecting KMT2D missense mutations in Kabuki syndrome patients. Hum Mol Genet 2018; 27 (21) 3651-3668
• 18 Cheon CK, Ko JM. Kabuki syndrome: clinical and molecular characteristics. Korean J Pediatr 2015; 58 (09) 317-324
• 19 Kawame H, Hannibal MC, Hudgins L, Pagon RA. Phenotypic spectrum and management issues in Kabuki syndrome. J Pediatr 1999; 134 (04) 480-485
• 20 Philip N, Meinecke P, David A. et al. Kabuki make-up (Niikawa-Kuroki) syndrome: a study of 16 non-Japanese cases. Clin Dysmorphol 1992; 1 (02) 63-77
• 21 Bekircan-Kurt CE, Şimşek-Kiper PO, Boduroğlu K, Dericioğlu N. A novel de novo mutation involving the MLL2 gene in a Kabuki syndrome patient presenting with seizures. Turk J Pediatr 2016; 58 (01) 97-100
• 22 Lodi M, Chifari R, Parazzini C. et al. Seizures and EEG pattern in Kabuki syndrome. Brain Dev 2010; 32 (10) 829-834
• 23 Kurahashi N, Miyake N, Mizuno S. et al. Characteristics of epilepsy in patients with Kabuki syndrome with KMT2D mutations. Brain Dev 2017; 39 (08) 672-677
• 24 Ogawa A, Yasumoto S, Tomoda Y, Ohfu M, Mitsudome A, Kuroki Y. Favorable seizure outcome in Kabuki make-up syndrome associated with epilepsy. J Child Neurol 2003; 18 (08) 549-551
• 25 Kasuya H, Shimizu T, Nakamura S, Takakura K. Kabuki make-up syndrome and report of a case with hydrocephalus. Childs Nerv Syst 1998; 14 (06) 230-235
• 26 Di Gennaro G, Condoluci C, Casali C, Ciccarelli O, Albertini G. Epilepsy and polymicrogyria in Kabuki make-up (Niikawa-Kuroki) syndrome. Pediatr Neurol 1999; 21 (02) 566-568